Sievers Caroline, Dimopoulou Christina, Pfister Hildegard, Lieb Roselind, Steffin Birgit, Roemmler Josefine, Schopohl Jochen, Mueller Marion, Schneider Harald Jörn, Ising Marcus, Wittchen Hans Ulrich, Stalla Guenter Karl
Departments of Endocrinology and Molecular Psychology, Max-Planck Institute of Psychiatry, Kraepelinstrasse 2-10, Munich, Germany.
Clin Endocrinol (Oxf). 2009 Nov;71(5):691-701. doi: 10.1111/j.1365-2265.2009.03555.x. Epub 2008 Feb 18.
Emotional and behavioural alterations have been described in acromegalic patients. However, the nature and psychopathological value of these changes remained unclear. We examined whether acromegalic patients have an increased prevalence of comorbid DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, 4th Version) mental disorders in comparison to subjects with or without chronic somatic disorders.
DESIGN/PATIENTS: A cross-sectional study was conducted at the Max-Planck Institute of Psychiatry and the Ludwig-Maximilians-University Munich. Eighty-one acromegalic patients were enrolled. Control subjects with (n = 3281) and without chronic somatic (n = 430) disorders were drawn from a representative sample of the German adult general population as part of the Mental Health Supplement of the German Health Interview and Examination Survey. Lifetime and 12-month prevalences of DSM-IV mental disorders were assessed with face-to-face interviews using the standardized German computer-assisted version of the Composite International Diagnostic Interview.
Acromegalic patients had increased lifetime rates of affective disorders of 34.6% compared to 21.4% in the group with chronic somatic disorders (OR = 2.0, 95% CI 1.2-3.2) and to 11.1% in the group without chronic somatic disorders (OR = 4.4, 95% CI 2.3-8.7). Affective disorders that occurred significantly more often than in the control groups began during the putative period of already present GH excess. Higher rates of DSM-IV mental disorders were reported in those patients with additional treatment after surgery.
Acromegaly is associated with an increased prevalence and a specific pattern of affective disorders. Greater emphasis on diagnosing and treatment of mental disorders in acromegalic patients might improve the disease management.
肢端肥大症患者存在情绪和行为改变。然而,这些变化的性质和精神病理学价值仍不明确。我们研究了与患有或未患有慢性躯体疾病的受试者相比,肢端肥大症患者共病《精神疾病诊断与统计手册》第四版(DSM-IV)精神障碍的患病率是否更高。
设计/患者:在马克斯·普朗克精神病学研究所和慕尼黑路德维希-马克西米利安大学进行了一项横断面研究。纳入了81例肢端肥大症患者。作为德国健康访谈与检查调查心理健康补充调查的一部分,从德国成年普通人群的代表性样本中选取了患有慢性躯体疾病(n = 3281)和未患有慢性躯体疾病(n = 430)的对照受试者。使用标准化的德语计算机辅助版综合国际诊断访谈通过面对面访谈评估DSM-IV精神障碍的终生患病率和12个月患病率。
肢端肥大症患者情感障碍的终生患病率为34.6%,相比之下,患有慢性躯体疾病组为21.4%(比值比[OR]=2.0,95%置信区间[CI]1.2 - 3.2),未患有慢性躯体疾病组为11.1%(OR = 4.4,95%CI 2.3 - 8.7)。与对照组相比,明显更常发生的情感障碍在假定的生长激素已经过量的时期开始。接受手术后额外治疗的患者报告的DSM-IV精神障碍发生率更高。
肢端肥大症与情感障碍患病率增加及特定模式相关。更加重视肢端肥大症患者精神障碍的诊断和治疗可能会改善疾病管理。